Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells

A Corrigendum to this article was published on 20 August 2009

Abstract

MicroRNAs (miRNAs) are important regulators of cell fate determination and homeostasis. Expression of these small RNA genes is tightly regulated during development and in normal tissues, but they are often misregulated in cancer. MiRNA expression is also affected by DNA damaging agents, such as radiation. In particular, mammalian miR-34 is upregulated by p53 in response to radiation, but little is known about the role of this miRNA in vivo. Here we show that Caenorhabditis elegans with loss-of-function mutations in the mir-34 gene have an abnormal cellular survival response to radiation; these animals are highly radiosensitive in the soma and radioresistant in the germline. These findings show a role for mir-34 in both apoptotic and non-apoptotic cell death in vivo, much like that of cep-1, the C. elegans p53 homolog. These results have been additionally validated in vitro in breast cancer cells, wherein exogenous addition of miR-34 alters cell survival post-radiation. These observations confirm that mir-34 is required for a normal cellular response to DNA damage in vivo resulting in altered cellular survival post-irradiation, and point to a potential therapeutic use for anti-miR-34 as a radiosensitizing agent in p53-mutant breast cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 3
Figure 2
Figure 4

Similar content being viewed by others

References

  • Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S et al. (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101: 2999–3004.

    Article  CAS  Google Scholar 

  • Derry WB, Putzke AP, Rothman JH . (2001). Caenorhabditis elegans p53: role in apoptosis, meiosis, and stress resistance. Science 294: 591–595.

    Article  CAS  Google Scholar 

  • Esquela-Kerscher A, Slack FJ . (2006). Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer 6: 259–269.

    Article  CAS  Google Scholar 

  • Gartner A, Milstein S, Ahmed S, Hodgkin J, Hengartner MO . (2000). A conserved checkpoint pathway mediates DNA damage-induced apoptosis and cell cycle arrest in C. elegans. Mol Cell 5: 435–443.

    Article  CAS  Google Scholar 

  • He L, He X, Lowe SW, Hannon GJ . (2007). microRNAs join the p53 network--another piece in the tumour-suppression puzzle. Nat Rev Cancer 7: 819–822.

    Article  CAS  Google Scholar 

  • Hui L, Zheng Y, Yan Y, Bargonetti J, Foster DA . (2006). Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D. Oncogene 25: 7305–7310.

    Article  CAS  Google Scholar 

  • Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S et al. (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065–7070.

    Article  CAS  Google Scholar 

  • Johnson CD, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K, Ovcharenko D et al. (2007). The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 67: 7713–7722.

    Article  CAS  Google Scholar 

  • Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A et al. (2005). RAS is regulated by the let-7 microRNA family. Cell 120: 635–647.

    Article  CAS  Google Scholar 

  • Ljungman M, Lane DP . (2004). Transcription—guarding the genome by sensing DNA damage. Nat Rev Cancer 4: 727–737.

    Article  CAS  Google Scholar 

  • Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S et al. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66–71.

    Article  CAS  Google Scholar 

  • Miska EA, Alvarez-Saavedra E, Abbott AL, Lau NC, Hellman AB, McGonagle SM et al. (2007). Most Caenorhabditis elegans microRNAs are individually not essential for development or viability. PLoS Genet 3: e215.

    Article  Google Scholar 

  • Runnebaum IB, Nagarajan M, Bowman M, Soto D, Sukumar S . (1991). Mutations in p53 as potential molecular markers for human breast cancer. Proc Natl Acad Sci USA 88: 10657–10661.

    Article  CAS  Google Scholar 

  • Salter KH, Acharya CR, Walters KS, Redman R, Anguiano A, Garman KS et al. (2008). An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer. PLoS ONE 3: e1908.

    Article  Google Scholar 

  • Vogelstein B, Lane D, Levine AJ . (2000). Surfing the p53 network. Nature 408: 307–310.

    Article  CAS  Google Scholar 

  • Weidhaas JB, Babar I, Nallur SM, Trang P, Roush S, Boehm M et al. (2007). MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res 67: 11111–11116.

    Article  CAS  Google Scholar 

  • Weidhaas JB, Eisenmann DM, Holub JM, Nallur SV . (2006). A Caenorhabditis elegans tissue model of radiation-induced reproductive cell death. Proc Natl Acad Sci USA 103: 9946–9951.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank the CGC for strains. MK was supported by a postdoctoral fellowship from the Uehara Life Science Foundation. JW was supported by the Breast Cancer Alliance and a K08 grant (CA124484) from the NIH and by an American Cancer Society Institutional Research Grant to the Yale Cancer Center and by the ASTRO Junior Faculty Career Research Training Award. FS was supported by a grant from the Ellison Medical Foundation. FS and JW were supported by a grant from the NIH (CA131301-01A1).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to J B Weidhaas or F J Slack.

Additional information

Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kato, M., Paranjape, T., Ullrich, R. et al. The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells. Oncogene 28, 2419–2424 (2009). https://doi.org/10.1038/onc.2009.106

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2009.106

Keywords

This article is cited by

Search

Quick links